Table 2.
Clinical laboratory data of the patients at baseline.
| Characteristic | Measurement |
|---|---|
| WBC count, per mm3, median (IQR) | 6100 (5500–7500) |
| Lymphocyte count, per mm3, median (IQR) | 840 (530–1085) |
| Eosinophil count, per mm3, median (IQR) | 0 (0–10) |
| AST level, U/L, median (IQR) | 45 (34–61) |
| ALT level, U/L, median (IQR) | 35 (24–49) |
| LDH level, U/L, median (IQR) | 327 (283–390) |
| CK level, U/L, median (IQR) | 95 (53–179) |
| BUN level, mg/dL, median (IQR) | 16 (13–24) |
| Cre level, mg/dL, median (IQR) | 0.85 (0.63–1.05) |
| eGFR, ml/min/1.7 m2, median (IQR) | 71.3 (54.8–83.1) |
| Zn level, μg/dL, median (IQR) | 55 (46–69) |
| Alb level, μg/dL, median (IQR) | 3.0 (2.8–3.5) |
| CRP level, mg/dL, median (IQR) | 7.4 (4.0–11.9) |
| Ferritin level, ng/mL, median (IQR) | 635 (412–1235) |
| PCT level, ng/mL, median (IQR) | 0.08 (0.05–0.16) |
| D-dimer level, μg/dL, median (IQR) | 0.6 (0.5–1.8) |
| sIL-2R level, U/mL, median (IQR) | 837 (740–1155) |
| KL-6 level, U/mL, median (IQR) | 327 (269–458) |
IQR, interquartile range; WBC, white blood cell; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; CK, creatinine kinase; BUN, blood urea nitrogen; Cre, creatinine; eGFR, estimated glomerular filtration rate; Alb, albumin; CRP, C-reactive protein; PCT, procalcitonin; sIL-2R, soluble interleukin-2 receptor; KL-6, Krebs von den Lungen-6.